Wednesday, July 8, 2026
Home Authors Posts by Ogkologos

Ogkologos

4276 POSTS 0 COMMENTS

Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients...

Ogkologos -
0

No Difference in DFS Between Post-adjuvant Chemotherapy and Placebo In High-Risk...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Enfortumab Vedotin

Ogkologos -
0

ESMO Joins WHO Global Clinical Trials Forum to Strengthen Global Oncology...

Ogkologos -
0

Selinexor plus Ruxolitinib Reduces Spleen Volume, but Does Not Improve Symptom...

Ogkologos -
0

FDA Approves Two Separate Indications for fam-Trastuzumab Deruxtecan-nxki in HER2-Positive Early-Stage...

Ogkologos -
0

ESMO Calls for Further EU Measures Enhancing Europe’s Clinical Trial Regulatory...

Ogkologos -
0

Reflections on Progress and Partnership at ASCO 2026

Ogkologos -
0

Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously...

Ogkologos -
0

ESMO Responds to Public Consultation on EU4Health Work Programme for 2027...

Ogkologos -
0
123...428Page 2 of 428

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com